U-100 Insulin Syringe 0.5mL 27G and 29G 의 리콜

Department of Health, Therapeutic Goods Administration에 따르면, 해당 리콜 는 Australia 에서 Terumo Australia Pty Ltd 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

의료기기에 문제가 생겼을 경우 제조사가 이를 바로잡거나 시장에서 회수하는 조치를 말한다. 회수(Recall)는 의료기기에 결함이 있거나, 건강에 위협이 되거나, 또는 결함도 있고 건강에도 위협이 될 경우에 발생한다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Recall
  • 사례 ID
    RC-2018-RN-00171-1
  • 사례 위험등급
    Class II
  • 사례 시작날짜
    2018-02-23
  • 사례 국가
  • 사례 출처
    DHTGA
  • 사례 출처 URL
  • 비고 / 경고
    Australian data is current through July 2018. All of the data comes from the Australian Therapeutic Goods Administration, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Australia.
  • 데이터 추가 비고
  • 원인
    Taechang industrial is initiating a recall of all lot numbers of terumo branded u-100 insulin syringe with a capacity of 0.5ml x 27g and 29g due to incorrect information contained on the device peel pack.The statement:"0.5ml single use syringe for 100 units or less in two unit increments"is incorrect and should state:"0.5ml single use syringe for 50 units or less in one unit increments"in essence, the 0.5ml peel packs have been inadvertently printed with information intended for the 1.0ml peel pack. the printing on the syringes themselves is correct.
  • 조치
    Terumo is requesting customers: 1. Review the supplied urgent medical device recall (permanent removal) notification, inspect all stock on hand and quarantine affected lot numbers prior to return as per the instructions given in the customer letter. Ensure all relevant staff are made aware of this recall; 2.If any of the recalled product could have been transferred from your facility to another, please immediately notify that facility know of this recall; 3.Where possible, return all affected stock to your supply department for consolidated return to Terumo Australia as per the instructions given; and 4.Terumo will be providing credit for all returned stock. Replacement stock will not be automatically issued. Please process a new order if more stock is required.

Device

  • 모델명 / 제조번호(시리얼번호)
    U-100 Insulin Syringe 0.5mL 27G and 29G Lot Numbers for product SS*05M2713KA: 7D700, 7E700, 7F731, 7G719, 7I701, 6H713,6K700 Lot Numbers for product SS*05M2913KA : 7A713, 7G720, 7I7012, 7A713, 7B728, 6F700, 6F706Multiple Lot Numbers (see attached)ARTG: 234082 (Terumo Australia Pty Ltd - Insulin syringe, fixed-needle)
  • Manufacturer

Manufacturer